Trial Profile
Efficacy of Rituximab at low doses in Multiple Sclerosis – A prospective, randomized, double-blind, active controlled, pilot trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2018
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms Low-dose Rituximab in MS
- 20 Apr 2018 New trial record